EX-32.1 6 albo-20190331ex321a08589.htm EX-32.1 albo_Ex32_1

Exhibit 32.1




Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Albireo Pharma, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:


The Quarterly Report for the quarter ended March 31, 2019 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.






Dated:  May 9, 2019


/s/ Ronald H.W. Cooper



Ronald H.W. Cooper



President and Chief Executive Officer



(principal executive officer)






Dated:  May 9, 2019


/s/ Simon Harford



Simon N.R. Harford



Chief Financial Officer and Treasurer



(principal financial officer and principal accounting officer)